Bluestein R H & CO LLC Intellia Therapeutics, Inc. Transaction History
Bluestein R H & CO LLC
- $1.61 Billion
- Q3 2022
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$117 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$94.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$89.3 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$48.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$35.5 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $707M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...